Abstract
Howard Bailey, MD, and Theodore S. Lawrence, MD, PhD, are highlighted.
Medical oncologist Howard Bailey, MD, became director of the University of Wisconsin Carbone Cancer Center in Madison on April 1; he had been serving as the center's interim director since September 2013. A professor of medicine at the university's School of Medicine and Public Health, he specializes in gynecologic and soft-tissue cancers and cancer prevention.
Bailey has worked as a cancer clinician and researcher since joining the faculty of the University of Wisconsin–Madison in 1994. He has led the development of three state- and nationwide clinical research networks to expand patients' access to clinical trials. In 2011, he was appointed to the committee that reviews all NCI-designated cancer centers. He is also the national chair of the American Society of Clinical Oncology's Cancer Prevention Committee.
Radiation oncologist Theodore S. Lawrence, MD, PhD, began his new role as director of the University of Michigan Comprehensive Cancer Center in Ann Arbor in February. He succeeds Max S. Wicha, MD, who founded the cancer center 27 years ago.
As director, Lawrence aims to increase partnerships with community cancer centers so that patients can receive high-quality care closer to their homes. He plans to continue serving as chair of radiation oncology and to remain involved in patient care and research activities as well. His laboratory work focuses on chemotherapeutic and molecularly targeted radiosensitizers. His clinical research combines his laboratory studies with conformal radiation guided by metabolic and functional imaging to treat patients with pancreatic and other gastrointestinal cancers.
A member of the faculty of the University of Michigan since 1987, Lawrence has served in leadership positions for several organizations.
For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.